CancerVax expects to launch its therapeutic melanoma vaccine and lead product candidate Canvaxin by 2006.
HS Treatment Response Rates Continue to Improve with Secukinumab at Week 52
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Losing a Malpractice Case May Depend on Where You Live
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
The Role We Play in Addressing Racial Disparity in Dermatology
The Mainstream Patient: February 2